AC Immune (ACIU) Competitors $2.06 +0.04 (+1.98%) Closing price 02:31 PM EasternExtended Trading$2.06 0.00 (0.00%) As of 04:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ACIU vs. CMRX, CDMO, AVBP, SNDX, IMNM, QURE, PHAR, XERS, CRON, and MENSShould you be buying AC Immune stock or one of its competitors? The main competitors of AC Immune include Chimerix (CMRX), Avid Bioservices (CDMO), ArriVent BioPharma (AVBP), Syndax Pharmaceuticals (SNDX), Immunome (IMNM), uniQure (QURE), Pharming Group (PHAR), Xeris Biopharma (XERS), Cronos Group (CRON), and Jyong Biotech (MENS). These companies are all part of the "pharmaceutical products" industry. AC Immune vs. Its Competitors Chimerix Avid Bioservices ArriVent BioPharma Syndax Pharmaceuticals Immunome uniQure Pharming Group Xeris Biopharma Cronos Group Jyong Biotech AC Immune (NASDAQ:ACIU) and Chimerix (NASDAQ:CMRX) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, earnings, analyst recommendations, dividends, profitability, media sentiment, institutional ownership and valuation. Is ACIU or CMRX more profitable? Chimerix has a net margin of 0.00% compared to AC Immune's net margin of -177.79%. AC Immune's return on equity of -44.60% beat Chimerix's return on equity.Company Net Margins Return on Equity Return on Assets AC Immune-177.79% -44.60% -22.25% Chimerix N/A -50.78%-44.94% Does the media prefer ACIU or CMRX? In the previous week, AC Immune had 2 more articles in the media than Chimerix. MarketBeat recorded 2 mentions for AC Immune and 0 mentions for Chimerix. AC Immune's average media sentiment score of 0.59 beat Chimerix's score of 0.00 indicating that AC Immune is being referred to more favorably in the media. Company Overall Sentiment AC Immune Positive Chimerix Neutral Which has higher valuation and earnings, ACIU or CMRX? AC Immune has higher revenue and earnings than Chimerix. Chimerix is trading at a lower price-to-earnings ratio than AC Immune, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAC Immune$31.02M6.67-$57.83M-$0.58-3.55Chimerix$212K3,778.71-$82.10M-$0.99-8.63 Which has more risk and volatility, ACIU or CMRX? AC Immune has a beta of 1.62, suggesting that its stock price is 62% more volatile than the S&P 500. Comparatively, Chimerix has a beta of -0.17, suggesting that its stock price is 117% less volatile than the S&P 500. Do institutionals and insiders have more ownership in ACIU or CMRX? 51.4% of AC Immune shares are held by institutional investors. Comparatively, 45.4% of Chimerix shares are held by institutional investors. 4.6% of AC Immune shares are held by company insiders. Comparatively, 13.1% of Chimerix shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Do analysts prefer ACIU or CMRX? AC Immune presently has a consensus price target of $12.00, indicating a potential upside of 482.52%. Chimerix has a consensus price target of $8.53, indicating a potential downside of 0.08%. Given AC Immune's stronger consensus rating and higher probable upside, research analysts clearly believe AC Immune is more favorable than Chimerix.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score AC Immune 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Chimerix 0 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 SummaryAC Immune beats Chimerix on 13 of the 16 factors compared between the two stocks. Get AC Immune News Delivered to You Automatically Sign up to receive the latest news and ratings for ACIU and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ACIU and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ACIU vs. The Competition Export to ExcelMetricAC ImmuneMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$202.83M$2.91B$5.54B$8.95BDividend YieldN/A2.42%5.38%4.08%P/E Ratio-3.5521.5627.4020.04Price / Sales6.67281.10419.46118.60Price / CashN/A41.9536.6357.47Price / Book1.607.518.085.67Net Income-$57.83M-$55.05M$3.16B$248.47M7 Day Performance-1.44%3.16%2.12%2.90%1 Month Performance24.85%5.92%4.43%5.75%1 Year Performance-45.93%5.82%35.62%21.36% AC Immune Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ACIUAC Immune2.6313 of 5 stars$2.06+2.0%$12.00+482.5%-47.8%$202.83M$31.02M-3.55140CMRXChimerix0.7511 of 5 stars$8.54flat$8.53-0.1%N/A$801.09M$212K-9.0990CDMOAvid Bioservices0.7159 of 5 stars$12.50+0.1%$12.25-2.0%+86.5%$799.18M$139.91M-5.23320News CoverageHigh Trading VolumeAVBPArriVent BioPharma1.7582 of 5 stars$21.77-5.0%$40.00+83.7%+14.6%$783.81MN/A-5.7740Gap DownSNDXSyndax Pharmaceuticals2.8396 of 5 stars$9.36+3.5%$35.80+282.5%-56.4%$777.87M$23.68M-2.42110Positive NewsIMNMImmunome2.543 of 5 stars$9.30+6.0%$23.33+150.9%-26.2%$763.10M$9.04M-2.9240Positive NewsHigh Trading VolumeQUREuniQure1.9788 of 5 stars$13.94+0.6%$37.82+171.3%+256.1%$759.19M$27.12M-3.18500News CoveragePHARPharming Group2.3807 of 5 stars$10.68-2.9%$30.00+181.0%+32.3%$748.58M$297.20M-53.38280Positive NewsHigh Trading VolumeXERSXeris Biopharma4.0896 of 5 stars$4.67-0.6%$6.25+33.8%+129.6%$735.01M$203.07M-15.57290Positive NewsCRONCronos Group2.3128 of 5 stars$1.91+0.5%N/A-11.9%$732.80M$117.61M14.69450News CoverageMENSJyong BiotechN/A$8.50-10.5%N/AN/A$722.26MN/A0.0031Analyst Upgrade Related Companies and Tools Related Companies Chimerix Competitors Avid Bioservices Competitors ArriVent BioPharma Competitors Syndax Pharmaceuticals Competitors Immunome Competitors uniQure Competitors Pharming Group Competitors Xeris Biopharma Competitors Cronos Group Competitors Jyong Biotech Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ACIU) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe $100 Trillion AI Story No One Is Telling YouJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AC Immune Please log in to your account or sign up in order to add this asset to your watchlist. Share AC Immune With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
